KPC Pharmaceuticals,Inc. (SHA:600422)
China flag China · Delayed Price · Currency is CNY
12.30
+0.04 (0.33%)
Feb 3, 2026, 3:00 PM CST

KPC Pharmaceuticals,Inc. Company Description

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People’s Republic of China and internationally.

It offers artemisia annua series, panax notoginseng, gastrodia, artemether, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections and others.

The company’s brands such as Luotai, Tianxuanqing, Artemedine, Artem and Arco. It markets artemisinin antimalarials, generic drugs, and medical apparatus.

The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015.

The company was founded in 1951 and is based in Kunming, the People’s Republic of China.

KPC Pharmaceuticals,Inc.
CountryChina
Founded1951
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Employees5,275
CEOWei Yan

Contact Details

Address:
No.166 Keyi Road
Kunming, 650106
China
Phone86 871 6831 9868
Websitekpc.com.cn

Stock Details

Ticker Symbol600422
ExchangeShanghai Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberCNE0000015P8
SIC Code2834

Key Executives

NamePosition
Wei YanPresident and Vice Chairman
Sun Zhi QiangFinancial Director
Zhang MengxunBoard Secretary and General Counsel
JunFeng LiuSenior Vice President
Li MengExecutive Vice President
Cheng SunVice President
Kai XiVice President
Tong GaoVice President
Li Chun LiVice President